Overview
David Ivill commented on proposed regulations in an article about 340B, after a recent OIG report found inconsistencies in how program participants determine if individuals qualify for the program. Mr. Ivill said they will hopefully have an impact on who is and isn’t eligible for 340B drugs. Read the full article
